Waters Co. (NYSE:WAT) Position Increased by Pathstone Holdings LLC

Pathstone Holdings LLC grew its holdings in shares of Waters Co. (NYSE:WAT) by 1.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,916 shares of the medical instruments supplier’s stock after purchasing an additional 65 shares during the period. Pathstone Holdings LLC’s holdings in Waters were worth $1,409,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Itau Unibanco Holding S.A. bought a new position in Waters in the second quarter worth about $33,000. Kennebec Savings Bank acquired a new stake in shares of Waters during the 3rd quarter worth approximately $33,000. Blue Trust Inc. lifted its holdings in shares of Waters by 190.2% in the 2nd quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 78 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Waters during the 3rd quarter valued at approximately $35,000. Finally, TFC Financial Management Inc. grew its stake in Waters by 19,900.0% during the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after buying an additional 199 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Performance

Shares of NYSE WAT opened at $386.57 on Friday. The stock’s fifty day simple moving average is $357.28 and its 200 day simple moving average is $332.98. The stock has a market capitalization of $22.95 billion, a price-to-earnings ratio of 36.89, a PEG ratio of 7.10 and a beta of 0.97. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. Waters Co. has a 52-week low of $273.60 and a 52-week high of $395.44.

Waters (NYSE:WAT) last issued its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share for the quarter, topping analysts’ consensus estimates of $2.68 by $0.25. Waters had a return on equity of 49.93% and a net margin of 21.43%. The firm had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. During the same quarter last year, the business posted $2.84 EPS. Waters’s revenue was up 4.0% on a year-over-year basis. As a group, sell-side analysts forecast that Waters Co. will post 11.79 earnings per share for the current fiscal year.

Analyst Ratings Changes

WAT has been the subject of several recent research reports. TD Cowen upped their price target on shares of Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Stifel Nicolaus raised their target price on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft lifted their target price on Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Leerink Partnrs raised Waters from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 1st. Finally, Cfra set a $389.00 price objective on shares of Waters in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Waters has a consensus rating of “Hold” and an average price target of $365.85.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.